subject area of
- A Peptide Antagonist of the TLR4-MD2 Interaction Journal Article
- An MD2 Hot-Spot-Mimicking Peptide that Suppresses TLR4-Mediated Inflammatory Response in vitro and in vivo Journal Article
- Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions Journal Article
- EVIDENCE THAT INTRATHECAL MORPHINE-3-GLUCURONIDE MAY CAUSE PAIN ENHANCEMENT VIA TOLL-LIKE RECEPTOR 4/MD-2 AND INTERLEUKIN-1 beta Journal Article
- EVIDENCE THAT TRICYCLIC SMALL MOLECULES MAY POSSESS TOLL-LIKE RECEPTOR AND MYELOID DIFFERENTIATION PROTEIN 2 ACTIVITY Journal Article
- Evidence that opioids may have toll-like receptor 4 and MD-2 effects Journal Article
- Lovastatin inhibits Toll-like receptor 4 signaling in microglia by targeting its co-receptor myeloid differentiation protein 2 and attenuates neuropathic pain Journal Article
- Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell Journal Article
- Morphine activates neuroinflammation in a manner parallel to endotoxin Journal Article
- POSSIBLE INVOLVEMENT OF TOLL-LIKE RECEPTOR 4/MYELOID DIFFERENTIATION FACTOR-2 ACTIVITY OF OPIOID INACTIVE ISOMERS CAUSES SPINAL PROINFLAMMATION AND RELATED BEHAVIORAL CONSEQUENCES Journal Article
- Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain Journal Article
- Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling Journal Article